GHK-Cu hair serums: what the peptide science actually shows

What did @peptyds.melbourne actually say?

Honestly? Not much. The transcript from this 29.8K-view video is entirely background music lyrics, with no spoken claims about the product at all. The actual claims live in the caption, which promises the serum will "support scalp health" and deliver "stronger, healthier, fuller-looking hair." The product is described as containing AHK-Cu, which the creator parenthetically equates with GHK-Cu, a copper-binding peptide that has genuine research behind it. So we're fact-checking a caption, not a spoken pitch.

That distinction matters. Caption claims are still advertising claims under Australian TGA guidelines, and a product being sold via phone number pre-order sits in a regulatory grey zone worth flagging before we even get to the science.

Does the science back this up?

There is real, peer-reviewed research on GHK-Cu and hair growth, but it's thinner than the marketing suggests. The existing evidence is mostly in vitro or small-scale, not the kind of double-blind, placebo-controlled trials you'd want before spending serious money.

Pickart and Margolina (2018, Cosmetics) reviewed GHK-Cu's biological activity and noted it can stimulate hair follicle size and support wound healing in skin tissue. Ahn et al. (2017, Journal of Dermatological Science) found that copper peptides promoted hair follicle cell proliferation in laboratory conditions. These are genuinely promising signals. But lab results don't automatically translate to a topical serum producing visible regrowth on a human scalp. AHK-Cu is a related but distinct tripeptide, and the research base for it specifically is even more limited than for GHK-Cu. Equating the two, as the caption does, is a stretch.

What did they get wrong (or right)?

Credit where it's due: framing this as supporting "the appearance" of healthier hair is actually more honest than most peptide hair product marketing. That hedge matters legally and scientifically.

What's problematic is the silent equation of AHK-Cu with GHK-Cu. These are different molecules. AHK-Cu is acetyl tetrapeptide-3 in cosmetic labeling, studied primarily in combination formulas. Calling it "GHK-Cu" in parentheses implies they are interchangeable, which the literature does not support. Patwardhan et al. (2021, International Journal of Trichology) noted that peptide-based hair products frequently make structure-function claims that outpace available clinical evidence. That's exactly what's happening here.

The biotin hashtag is also worth questioning. Biotin supplementation only shows measurable hair benefit in people with documented biotin deficiency, which is rare. Using it as a credibility signal for a peptide serum is misleading by association.

What should you actually know?

If you're serious about hair loss, GHK-Cu is a legitimate research target, but it is not a proven clinical treatment. Minoxidil and finasteride remain the only TGA-approved topical and oral options with substantial evidence behind them. A peptide serum sold via a phone number pre-order, without listed concentration, formulation stability data, or clinical trial results, is speculative at best.

Topical peptide delivery also has a real absorption problem. Peptides are large molecules that struggle to penetrate the skin barrier effectively. Without a delivery system designed to address this, much of the active ingredient may never reach the follicle. The caption does not mention any such system.

• Ask any vendor for: active peptide concentration, stability testing results, and any human clinical data.
• If hair loss is significant, see a dermatologist before spending money on unregulated serums.
• "Appearing fuller" is not the same as regrowing hair. Read those words carefully.

The regulatory angle you shouldn't ignore

Australia's TGA regulates therapeutic claims on cosmetic and skincare products. Claims that a product will "support scalp health" and improve hair fullness can cross the line into therapeutic territory, depending on how they're presented. Selling pre-orders via a mobile phone number, without a visible TGA registration or ARTG listing, raises compliance questions that consumers deserve to ask about directly. This does not mean the product is unsafe, but it does mean there is no independent verification of quality, concentration, or sterility standards in place.